PARTICIPATING COMPANIES

Companies participating at Biotech Showcase 2022 to date

 
United States

1859

 
United States

11 Health & Technologies Inc

 
United States

180 Life Sciences Corp.

 
 
United States

203 Investment Partners

 
 
Monaco

3B Future Health Ventures

 
 
United States

3CC

 
 
United States

3E Bioventures Capital

 
 
United Kingdom

4BIO Capital

 
France

4P-PHARMA

 
 
United States

6 Dimensions Capital

 
United States

7 Hills Pharma LLC

 
 
United States

7G BioVentures

 
United States

Aagami, Inc.

 
United States

A-Alpha Bio

 
United States

Aardvark Therapeutics

 
Canada

AbCellera Biologics

 
United States

Abcentra

 
 
United States

ABES Venture Partners

 
United States

Abintus Bio, Inc.

 
Canada

ABOzymes Biomedical Inc.

 
Australia

Acclime Australia Pty Ltd

 
 
United States

Aceras Life Sciences

 
United States

Achelios Therapeutics

 
France

ACTICOR BIOTECH

 
United Kingdom

Actimed Therapeutics

 
United States

Actinium Pharmaceuticals

 
 
United States

Acuris Partners

 
Australia

AdAlta Ltd

 
United States

ADHD Online LLC

 
 
United States

Adi Family Office

 
United States

Adjuvance Technologies Inc

 
United States

Adjuvant Partners

 
 
Canada

adMare BioInnovations

 
France

Adocia

 
United States

Adze Biotechnology Inc

 
Belgium

Aelin Therapeutics NV

 
France

AFFILOGIC

 
 
Japan

Aflac Ventures Japan

 
United States

AGC Biologics

 
Japan

AGC Chemicals, AGC Inc.

 
 
United States

Agent Capital

 
United States

Agenus

 
United States

Agile Therapeutics

 
 
United States

Agilent - Early Stage Partnerships

 
Australia

Agilex Biolabs

 
 
Netherlands

Aglaia Oncology Funds

 
Spain

AHEAD THERAPEUTICS SL

 
United States

AI Time Journal

 
Germany

AiCuris Anti-infective Cures AG

 
 
United States

Aisling Capital

 
United States

AIVITA Biomedical

 
Japan

AJINOMOTO Co. Inc.

 
United States

Akadeum Life Sciences, Inc.

 
United States

Albireo Pharma, Inc.

 
United Kingdom

Albumedix

 
United States

Aleon Pharma International, Inc.

 
 
United States

Alignment Ventures, LLC

 
United States

Alira Health

 
United States

Allele Capital Partners LLC

 
United States

AllerGenis

 
Taiwan

Allgenesis Biotherapeutics Inc.

 
United States

Alliance for Regenerative Medicine - Washington, DC

 
United States

AllStripes

 
 
Switzerland

Alpha Blue Ocean advisers Ltd

 
Israel

Alpha Tau

 
United States

AlphaSense

 
 
Spain

ALTA LIFE SCIENCES

 
 
United States

Alta Ventures

 
South Korea

Alteogen Inc.

 
United States

Altimmune

 
 
United States

Altium Capital Management, LP

 
United States

AltruBio Inc.

 
United States

Alveolus Bio

 
France

Alzprotect

 
United States

Amaro Therapeutics, Inc.

 
United States

Amneal Pharmaceuticals

 
 
Canada

AmorChem

 
United States

AMPEL BioSolutions

 
United States

Amplity Health

 
South Korea

AmtixBio Co., Ltd.

 
 
France

Andera Partners

 
 
United States

Angel Investor

 
 
United States

Angels + Life.Sci Investors NJAngels.net

 
United States

Angex Pharmaceutical Inc

 
United States

AnHeart Therapeutics

 
United States

Annovis Bio

 
France

ANTABIO SAS

 
Israel

Aposense

 
France

Apparius

 
 
United States

Apple Tree Partners

 
United Kingdom

Aptorum Group Limited

 
United States

Aqua Partners LLC

 
United States

Aqualung Therapeutics, Corp.

 
South Korea

Arbormed Co., Ltd

 
 
United States

ARCH Venture Partners

 
United Kingdom

Arctoris

 
Belgium

Ardena

 
 
United States

ARDIAN

 
United States

Arena Pharmaceuticals

 
United States

Aria Pharmaceuticals

 
United States

Ariel Precision Medicine, Inc.

 
 
United States

Aristar Capital

 
United States

Aristea Therapeutics

 
 
United Kingdom

Arix Bioscience

 
United States

Arizona Bioindustry Association (AZBio)

 
Australia

Arovella Therapeutics

 
 
United Kingdom

Arrowfield Capital

 
United States

Artax Biopharma

 
United States

Arterez, Inc.

 
South Korea

Arum Therapeutics INC

 
 
Spain

Asabys Partners

 
 
United States

Asahi Kasei Pharma Corporation

 
 
United States

Asahi Kasei Ventures

 
United States

Ascendia Pharmaceuticals, Inc.

 
 
United States

Ascendiant Capital

 
 
United Kingdom

Ascension Ventures Life Fund

 
United States

ASDERA LLC

 
United States

Ash Ingredients, Inc.

 
Japan

ASKA Pharmaceutical

 
 
France

ASKLEPIOS ADVISORS

 
Canada

Aspect Biosystems

 
United States

Astellas Pharma Inc.

 
 
United States

Astellas Venture Management LLC

 
 
United States

Astia

 
United States

Astrocyte Pharmaceuticals

 
United States

ASYMCHEM BOSTON CORP

 
 
United States

Asymmetry Ventures

 
 
United States

Ataraxia Partners

 
Belgium

atb therapeutics

 
 
United States

ATEM Capital

 
 
United States

Athena Bioventures

 
Germany

Atriva Therapeutics GmbH

 
Sweden

Attana AB

 
United States

Attivare Tx

 
Singapore

AUM Biosciences

 
United States

Aurigene Pharmaceutical Services Ltd

 
 
Italy

AurorA Science srl

 
United States

Avalo Therapeutics

 
 
United States

Avalon Bioventures

 
United States

Avammune Therapeutics Inc.

 
Australia

Avance Clinical

 
Ireland

Avectas

 
United States

Avion Pharmaceuticals

 
Switzerland

Avrion Therapeutics AG

 
United Kingdom

Avvinity Therapeutics

 
United Kingdom

Axovia Therapeutics

 
United States

Azitra

 
 
United States

B Capital Group

 
 
United States

B. Riley Securities

 
United States

Bachem Americas, Inc.

 
United States

Back Bay Life Science Advisors

 
France

BACKBONE

 
United States

BacVax, Inc.

 
France

BASECAMP VASCULAR

 
United States

Baudax Bio

 
United States

Bayer Pharmaceuticals

 
 
United States

BayMed Venture Partners

 
Ireland

BCO Pharma

 
 
United States

Benchmark Company

 
 
United States

Bering Capital

 
 
United States

Berkeley Angel Network

 
United States

Bexion Pharmaceuticals, Inc.

 
 
Japan

Beyond Next Ventures Inc.

 
South Korea

BeyondBio Inc

 
 
Netherlands

BGV

 
 
South Korea

Bigbang Angels,Inc.

 
United States

Bilayer Therapeutics, Inc.

 
 
United States

Bill & Melinda Gates Foundation

 
 
United States

BIMA Capital, LLC

 
 
United States

Bio 9 Ventures

 
 
India

Bio Ideations LLP

 
United States

BioAge Labs

 
United States

Bioasis Technologies Inc.

 
United States

BioBuzz Media

 
United Kingdom

BIOCAPTIVA Limited

 
United States

BioCentury

 
Australia

BioCina

 
United States

Biocom California

 
United States

BioCurity Pharmaceuticals Inc.

 
China

Biocytogen PharmaceuticalsBeijingCo., Ltd.

 
United States

BioDirectors, LLC

 
 
Taiwan

BioEngine Capital, Inc. ( A venture arm of Center Laboratories)

 
 
United States

BioHealth Capital Fund

 
Sweden

BioInvent International AB

 
Romania

Bioinvest

 
South Korea

BioLeaders Corp.

 
Sweden

Biomapas Nordic AB

 
France

Biomunex Pharmaceuticals

 
France

Bionest Partners

 
United States

Bioniz Therapeutics

 
United Kingdom

BioPartner UK

 
United States

Biopharma Global

 
United States

Biophytis

 
 
Belgium

Bioqube Ventures

 
 
United States

BioRock Ventures I, LP

 
 
United States

Bios Partners

 
 
Australia

BioScience Managers

 
 
United States

Bioscience Navigators

 
United States

BioSpace

 
United States

BioSymetrics

 
 
United States

Biotech Investment Group

 
 
Netherlands

Biotech Mountains BV

 
United States

Bio-Thera Solutions

 
Germany

Biotheus, Inc.

 
United States

Biotricity Inc

 
 
United States

BioValleyCHINA Ventures

 
 
United States

Bioverge

 
Switzerland

BioVersys Ag

 
United States

BioWorld

 
 
United States

BL/SH Financial

 
 
United States

Black Opal Ventures, LLC

 
 
South Korea

Bluepoint Partners

 
Austria

BlueSky Immunotherapies

 
United States

Body Vision Medical

 
South Korea

BODYFRIEND

 
South Korea

Boryung Pharmaceutical

 
 
United States

Boston Financial, LLC

 
 
France

bpifrance

 
United States

Brainstorm Cell Therapeutics

 
 
United States

Brandon Capital Partners

 
 
United States

Brandt Venture Development

 
 
United States

Breakout Ventures

 
France

Brenus Pharma

 
 
Switzerland

BRESLIN AG

 
United States

Bridge - your iCCO company

 
United States

BridgeBio Pharma

 
Canada

Bright Minds Biosciences Inc.

 
United States

Brinter Inc

 
 
United States

Broadview Ventures

 
 
United States

Brookline Capital Markets

 
 
France

BROTHERS & PARTNERS EUROPE

 
 
United States

BTIG

 
United States

Burke Neurological Institute

 
Canada

Business France

 
United States

Business Insider

 
Sweden

Business Region Goteborg

 
United States

Buto Corporation

 
 
United States

Button Capital

 
 
United States

BVCF Management Ltd.

 
 
United States

C.M. Capital

 
United States

C3 Research Associates

 
 
United States

CaaS Capital Management

 
United States

Caladrius Biosciences, Inc.

 
United States

California Israel Chamber of Commerce (CICC)

 
France

Calixar

 
United States

Cancer Research Institute

 
Israel

Cannasoul Analytics Ltd

 
United States

Cannex Scientific Inc

 
 
United States

Cantilever Investors

 
 
United States

Capgenic Advisors, LLC

 
France

CARDIAWAVE

 
 
Germany

CARELA HOLDING

 
Australia

Carina Biotech Pty Ltd

 
 
United States

Carpe Biosciences

 
United States

Case Western Reserve University

 
 
United States

Cassel Salpeter, LLC

 
United States

Catalyst Clinical Research

 
 
Israel

Catalyst Investments

 
 
United States

Catalytic Impact Foundation

 
United States

Catalytic Life Sciences, Inc

 
 
United Kingdom

Cathay Capital Health

 
United States

Celero Systems, Inc.

 
United States

Cell Harbor

 
South Korea

Cellatoz Therapeutics, Inc.

 
South Korea

Cellivery Therapeutics, Inc.

 
 
United States

Celtic House Asia Partner

 
United States

Center for Global Health Innovation

 
 
Canada

Centre for Aging + Brain Health Innovation

 
 
United States

CentreGold Capital

 
United States

Certara

 
United States

CFB Interests, LLC

 
United States

CG Life

 
United States

Chameleon Biosciences, Inc.

 
 
United States

chardan

 
United States

CheckOrphan

 
Canada

Chimeric Therapeutics Limited

 
United States

Chimeron Bio

 
China

China Resources Sanjiu Medical & Pharmaceutical Co., ltd

 
United States

ChinaBio Group

 
Canada

Chinook Therapeutics, Inc

 
United States

Choose New Jersey

 
United States

Chrysalis BioTherapeutics, Inc.

 
United States

Cincinnati Children's Hospital

 
United States

Citius Pharmaceuticals, Inc.

 
Canada

Clairvoyant Therapeutics Inc.

 
United States

Clarametyx Biosciences, Inc.

 
 
United States

Claremont Creek Ventures

 
United States

Clarigent Health

 
United States

CLEARLIGHT BIOTECHNOLOGIES Inc

 
 
United States

Cleveland Clinic

 
United States

ClostraBio, Inc.

 
United States

Coagulant Therapeutics Corporation

 
 
United States

Coast BioVentures LLC

 
United States

Coastar Therapeutics Inc.

 
United States

Cognition Therapeutics, Inc.

 
United States

Cognito Therapeutics, Inc.

 
Belgium

Cognivia

 
United States

Colorado State University

 
 
South Korea

Company K Partners

 
United States

Concerto Biosciences, Inc.

 
 
United States

Connecticut Innovations

 
United States

Connext Co., Ltd.

 
United States

Consulate of Canada

 
United States

Context Therapeutics Inc.

 
United States

ContraFect

 
 
Switzerland

Convergence Partners AG

 
United States

CorMedix Inc.

 
 
United States

Cortado Ventures

 
 
United States

Cota capital

 
Singapore

COVATE PHARMA

 
United States

CPC Scientific Inc.

 
 
United States

CR Ventures

 
 
United States

Craig-Hallum Capital Group

 
 
United States

Cresco Advisors LLC

 
United States

Crimson BioPharma

 
France

CROSSJECT

 
United States

Cryoport Systems

 
United States

CTI

 
 
Canada

CTI Life Sciences Fund

 
United States

Cullgen Inc.

 
 
United States

Cura Capital

 
Canada

Cura Therapeutics

 
South Korea

Curacle

 
France

curadigm

 
United States

Curi Bio

 
United States

Curia (formerly AMRI)

 
Japan

Curreio, Inc.

 
Canada

Cybin Inc.

 
United States

Cyclacel Pharmaceuticals, Inc.

 
United States

Cyclo Therapeutics, Inc

 
United States

Cytoimmune Therapeutics LLC

 
United States

Cytonus Therapeutics

 
Japan

CytoPathfinder,Inc.

 
Sweden

Cyxone AB

 
France

Da Volterra

 
 
United States

Dabar Investment Associates

 
 
South Korea

Daejoong Life Science Co., Ltd.

 
South Korea

Daewoong Pharmaceutical Co., Ltd.

 
 
United States

Dalton Venture

 
 
United States

Dan Duffy (private investor)

 
 
United States

David Fox Syndicate

 
 
United States

DaVita Venture Group

 
United States

DavosPharma

 
 
United Kingdom

DeBere Capital Partners

 
 
Switzerland

Debiopharm Innovation Fund SA

 
 
United States

Decheng Capital

 
United States

DeckTherapeutics Inc

 
 
United States

DEFTA Partners,Co

 
France

DEINOVE

 
United States

Delaware Innovation Space

 
United States

Delta TpX, Inc.

 
United States

Dendreon

 
United Kingdom

Destiny Pharma plc

 
 
United States

DFB Pharmaceuticals

 
 
United States

DHVC

 
Israel

DIA Imaging Analysis

 
France

DIACCURATE SA

 
United States

Diapin Therapeutics LLC

 
United States

Diffusion Pharmaceuticals Inc.

 
France

Domain Therapeutics

 
South Korea

Dong-A ST

 
 
United States

Dorset Capital LLC

 
 
Belgium

Droia Ventures

 
United States

DS InPharmatics.com

 
 
United States

Duce Management, LLC.

 
 
United States

Dynamk Capital

 
Japan

EA Pharma Co., Ltd.

 
 
Switzerland

Earlybird

 
 
United States

Easton Capital Investment Group

 
China

Eccogene

 
 
United States

Echo Investment Capital

 
 
Switzerland

Eclosion Ventures

 
United Kingdom

Edinburgh Molecular Imaging Ltd

 
Japan

Edit Force, Inc.

 
 
Puerto Rico

EGB Ventures

 
France

EGLE THERAPEUTICS

 
 
Israel

Eight Bridges

 
 
United States

Eight Partners VC, LLC

 
 
Japan

Eisai

 
Japan

Elix, Inc.

 
United States

Elixirgen Therapeutics, Inc.

 
United Kingdom

Ellipses Pharma Ltd

 
United States

Elpis Biopharmaceuticals

 
 
United States

Emci Fund

 
Germany

EMD Serono

 
 
United States

Emerald Bioventures

 
United States

Emergent BioSolutions

 
United States

Enalare Therapeutics Inc.

 
United States

Encellin

 
United States

Endevica Bio

 
United States

ENDRA Life Sciences

 
United States

Endure Biotherapeutics

 
United States

Engine Rooom

 
United States

Entac Medical Inc

 
United States

Enteris BioPharma

 
United Kingdom

EnteroBiotix

 
United States

Entos

 
United States

ENYO Pharma

 
United States

Enzychem Lifesciences

 
United States

Enzyvant

 
United States

Enzyvant Therapeutics

 
 
United States

Epidarex Capital

 
Japan

Epigeneron, Inc

 
Japan

e-Projection K.K.

 
France

Ermium Therapeutics

 
France

E-SCOPICS

 
Mexico

Escuela de Rx SAS de CV

 
 
United Kingdom

ESM Biotech Ltd

 
 
United Kingdom

Esperante

 
United States

Esperovax, Inc

 
France

EURASANTE

 
 
France

Eurekare

 
Canada

Eurofins CDMO Alphora

 
South Korea

Eutilex

 
United States

Evaluate

 
United States

Evecxia Therapeutics, Inc.

 
United Kingdom

Evgen Pharma Plc

 
 
United States

Evolution Life Sciences Partners

 
 
Singapore

EVX Ventures

 
United States

Exacis Biotherapeutics

 
United Kingdom

Exogene

 
 
United States

Exome Asset Management

 
United Kingdom

Exonate

 
Australia

Exopharm Ltd

 
 
United States

Fast Track Initiative

 
United States

Fe Pharmaceuticals

 
Canada

Feldan Therapeutics

 
United States

Felicitex Therapeutics, Inc.

 
 
United States

FemHealth Ventures

 
Denmark

Ferring

 
Germany

FGK Clinical Research GmbH

 
United States

Filtricine, Inc.

 
 
Sweden

Flerie Invest

 
United States

Florence Healthcare

 
 
United States

Flu Lab

 
 
United States

FMG Ventures

 
 
United States

Foothill Ventures

 
 
Netherlands

Forbion

 
 
United States

Fortunatus Capital

 
 
United States

Fountain Healthcare Partners

 
 
United States

F-Prime Capital

 
United States

FUJIFILM Diosynth Biotechnologies

 
 
Belgium

Fund+

 
 
United States

Fusion Fund

 
Netherlands

Gadeta

 
United States

Gain Therapeutics, Inc.

 
 
United States

Gaingels

 
Denmark

Galecto Biotech

 
United States

GBI

 
South Korea

GC Pharma

 
 
United States

GCF Family Office

 
 
United States

GEM

 
 
Japan

Gemseki Ventures L.P.

 
 
Canada

Genesys Capital Partners

 
United Kingdom

GENETIC MICRODEVICES LTD

 
United States

GeneToBe, LLC

 
United States

GeniPhys

 
France

Genopole

 
United States

Genoskin

 
United States

Genprex, Inc.

 
United States

GenScript USA Inc

 
United States

GeoVax Labs, Inc.

 
South Korea

GI Biome

 
South Korea

GI Cell

 
South Korea

GI Innovation

 
Canada

Giiant-Pharma

 
 
Germany

Gimv

 
United States

Ginkgo Bioworks

 
 
United States

Global Alpha Ventures

 
 
United States

Global Founders Capital

 
United States

Global Genes

 
 
United States

Global Health Investment Corporation

 
 
United States

Global Source Ventures LLC

 
United States

Glooko, Inc

 
Japan

GN Corporation Co Ltd

 
 
United States

Good Health Capital (New York)

 
United States

Goodwin Biotechnology, Inc.

 
 
United States

Green Park & Golf Ventures

 
 
United States

Greenfire Bio

 
 
Canada

GreenSky Capital

 
United States

Greenwich LifeSciences

 
Spain

Grifols SA

 
 
United States

GSR Ventures

 
China

Guangzhou Doublle Bioproduct Co., Ltd.

 
 
United States

Guoqian VC

 
 
United States

H.C Wainwright

 
 
United States

H.I.G. Capital

 
United States

H42.inc

 
 
Norway

Hadean Ventures

 
 
United States

Hairun Capital

 
United States

Halo Biosciences

 
South Korea

Hanmi Pharm., Co., Ltd.

 
 
United States

Hatch Biofund

 
Puerto Rico

HAYIM Group, LLC

 
 
United States

HBS Alumni Angels of Northern California

 
Japan

Healios K.K.

 
Switzerland

Healiva SA

 
United States

Healogics

 
United States

Health Advances

 
United States

Health Catalysts Group

 
 
United States

Health Equity Capital

 
 
United States

Health Innovation Capital

 
United States

HealthBeacon

 
United Kingdom

Healx Limited

 
 
United States

HEDA Ventures

 
 
United States

Helicase Venture

 
United States

Helsinn

 
Germany

HepaRegeniX GmbH

 
United States

Hepion Pharmaceuticals, Inc.

 
Finland

Herantis Pharma Plc

 
 
United States

Hercules Capital

 
 
Singapore

Heritas Capital Management Pte Ltd

 
 
Monaco

Hestia Investments Ltd.

 
 
Jordan

Hikma Ventures

 
 
China

Hillhouse Capital

 
United States

Hirodika Biosciences, Inc

 
China

HitGen Inc.

 
United States

HOF Therapeutics

 
United States

Hogan Lovells

 
United States

Homology Medicines

 
 
United States

Hongjing Capital

 
 
United States

Horizon Technology Finance

 
United States

Horizon Therapeutics

 
 
Italy

HTH Srl

 
South Korea

Huons

 
United States

HUYABIO INTERNATIONAL, LLC

 
United States

Hyalo Technologies

 
South Korea

HysensBio Co., Ltd.

 
South Korea

Hyun & Partners Korea

 
 
United States

Iaso Ventures

 
Ireland

ICON

 
United States

i-Cordis, LLC

 
United States

Idience Co., Ltd.

 
United Kingdom

IESO Digital Health

 
United States

IKTOS INC

 
 
United States

Illumina Ventures

 
Sweden

Ilya Pharma

 
United States

I-Mab Biopharma

 
Canada

Imeka

 
France

IMESCIA

 
Canada

Immugenia Inc.

 
United States

Immunexpress, Inc.

 
United States

Immunicom

 
United States

ImmunoGenesis, Inc.

 
United States

Immunomic Therapeutics, Inc.

 
United States

Immunophotonics, Inc

 
United States

Impact Capital Group, Inc.

 
Liechtenstein

Implantica AG

 
Australia

Imugene Limited

 
United States

IMV Inc.

 
United States

IN8bio, Inc.

 
 
Italy

Indaco Venture Partners Srl SGR

 
 
United States

Individual Investor

 
 
United States

Individual Investor - Wistar Morris

 
Germany

InfanDx AG

 
United Kingdom

Informa Plc

 
 
Netherlands

Inkef Capital BV

 
 
United States

InnoCom Bio Equities, Inc.

 
Spain

INNOUP FARMA

 
Japan

Innovacell K.K.

 
 
China

Innovent Fund

 
 
Germany

INOGROUP

 
 
United States

inovation ventures

 
United States

Inovio Pharma Inc.

 
Denmark

INPROTHER

 
 
United States

Insight Partners

 
United States

Integrated Biotherapeutic Vaccines, Inc.

 
United States

Integrated Computer Solutions

 
Switzerland

InterAx Biotech AG

 
 
United Kingdom

Intermediate Capital Group

 
Netherlands

InteRNA Technologies

 
United States

Invectys, Inc

 
Austria

invIOs

 
 
United States

Ionic Ventures LLC

 
Sweden

IP Enabler

 
 
United States

IP Group Inc.

 
 
Switzerland

IPF Partners

 
United States

Ipsen

 
United States

IQVIA

 
Australia

Island Pharmaceuticals Ltd.

 
 
Italy

Italian Angels for Growth

 
United Kingdom

Ixaka Limited

 
 
Japan

JAFCO Group Co. Ltd.

 
United States

Jaguar Health, Inc.

 
Japan

Japan External Trade Organization (JETRO)

 
 
United States

JDRF T1D Fund

 
 
France

Jeito Capital

 
China

Jiangsu Atom Bioscience and Pharmaceutical Co. Ltd.

 
Japan

Jiksak Bioengineering, Inc

 
China

Jilin Huisheng Bio-pharmaceutical Co.,

 
 
United Kingdom

JJDC

 
 
United States

Johnston Assoc. Inc.

 
United States

JPMorgan

 
United States

JT Pharma

 
United States

Jubilant Biosys Ltd.

 
 
United States

Julz Co LLC

 
South Korea

JUVIC Inc.

 
Finland

Kaiku Health

 
United States

Kairos Bioconsulting LLC

 
United States

KaloCyte, Inc.

 
South Korea

Kanaph Therapeutics

 
Japan

Kaneka Corporation

 
United Kingdom

Karma Oncology

 
United States

KBI Biopharma

 
United States

KeifeRx

 
 
United States

Keiretsu Forum Mid Atlantic

 
United States

Kernal Biologics

 
United States

Keystone Bio, Inc.

 
 
United States

Khosla Ventures

 
United States

Kikaku America International

 
France

KINATHERA

 
United States

Kineticos Life Sciences

 
Italy

KLISBio

 
United States

Knoubis Bio

 
 
United States

Korea Investment Partners

 
United States

Kowa Research Institute

 
Canada

KreaMedica Inc.

 
 
United Kingdom

Kreos Capital

 
Germany

Kupando GmbH

 
 
France

Kurma Partners

 
 
Japan

Kyoto University Innovation Capital

 
Japan

Kyowa Kirin Co., Ltd.

 
 
United States

Kyto Technology and Life Science

 
United States

La Jolla Institute for Immunology

 
United Kingdom

Labcorp

 
United States

Lactocore Inc.

 
 
United States

Ladenburg Thalmann

 
 
United States

Lair East Labs

 
United States

LambdaVision Incorporated

 
 
United States

Landmark Family Offfice

 
United States

Lassogen, Inc.

 
 
United States

Lateral Capital Advisors, LLC

 
United States

Latham BioPharm Group

 
 
China

Laurel Venture Capital

 
Canada

Laurent Pharmaceuticals

 
South Korea

LegoChem Biosciences

 
 
United States

LEO Pharma

 
United States

Leukemia & Lymphoma Society

 
 
United States

LevGo

 
United States

Levolta Pharmaceuticals

 
South Korea

LG Chem

 
Netherlands

Liberi Group

 
 
United States

Life Science Angels

 
United States

LifeSci Partners

 
 
United States

Lightchain Capital

 
 
Singapore

Lightstone Ventures

 
 
China

Lilly Asia Ventures

 
United States

Lilly USA, LLC - Indianapolis, IN

 
 
United States

Lincoln Park Capital LLC

 
United States

Linnaeus Therapeutics

 
 
Israel

LionBird

 
South Korea

LISCure Biosciences Inc.

 
United States

LiveCare

 
 
United States

Livingston Securities LLC

 
United States

Livivos Inc

 
 
Switzerland

LongeVC

 
 
United States

Longevity Vision Fund

 
 
United States

Longtail Healthcare Ventures

 
United States

Lonza

 
 
China

LoyalValley Capital

 
 
United Kingdom

LSV Capital Limited

 
United States

Luciole Pharmaceuticals

 
Australia

Luina Bio Pty Ltd

 
United States

Luminary Therapeutics, Inc.

 
 
Canada

Lumira Ventures

 
Taiwan

Lumosa

 
Israel

Lutris Pharma

 
 
United States

Lyfe Capital

 
 
United States

Lymo Ventures LP

 
 
China

Lynx Capital HK Limited

 
 
United States

Lynx1 Capital

 
Japan

M Bio Technology Inc.

 
 
Germany

M Ventures

 
United States

M3 Therapeutics, Inc.

 
Switzerland

Mabylon AG

 
United Kingdom

Macrophage Pharma Limited

 
Australia

Macuject Pty Ltd

 
United States

MaidStone Life Sciences LLC

 
United States

MAPS Public Benefit Corporation

 
 
United States

Marathon Asset Management

 
Japan

Maruho Co., Ltd.

 
United States

Maryland Life Sciences

 
United States

MassBio

 
United States

Matica Biotechnology

 
United States

Maxwell Biosciences, Inc.

 
 
Singapore

MBK Healthcare Management Pte Ltd

 
South Korea

MD HEALTHCARE INC., Tatyana Dyshenova

 
United States

Medable

 
Germany

Medac GmbH

 
 
United States

MedExplore Ventures

 
 
China

Med-Fine Capital

 
United States

MedGene Therapeutics

 
United States

Medical AI Inc

 
 
Japan

Medical Incubator Japan K.K.

 
Canada

MEDICENNA Therapeutics

 
France

MedinCell

 
Canada

Mediphage Bioceuticals

 
United States

MediPrint Ophthalmics

 
United Kingdom

MediSieve Limited

 
United States

MEDiSTRAVA

 
 
South Korea

Medivate Partners, LLC

 
United States

MedRhythms

 
Japan

MEDRx Co., Ltd.

 
 
United Kingdom

Meltwind Advisory

 
United States

Merand Pharmaceuticals, Inc.

 
United States

Merck & Co., Inc.

 
Germany

Merck Healthcare KGaA

 
United States

Mercy BioAnalytics Inc.

 
United States

Mergermarket - Acuris company - ION Group

 
 
United States

Mesa Verde Venture Partners

 
United Kingdom

Mesenbio

 
United States

Mesoblast

 
United States

Metaclipse Therapeutics

 
United States

metaMe Health

 
Japan

Metcela Inc.

 
 
United States

Meyers Investments Family LP

 
Australia

Microba Life Sciences

 
United Kingdom

Microbiotica

 
United States

MicroCures, Inc.

 
United States

Micron Biomedical

 
 
United States

Mid Atlantic Bio Angels

 
 
Russian Federation

Millhouse

 
 
South Korea

Mint Venture Partners

 
 
United States

Mira Life Science Ventures Inc.

 
 
South Korea

Mirae Asset Capital

 
South Korea

Mirae Asset Venture Investment

 
 
United States

MIT Alumni Angels

 
South Korea

MitoImmune Therapeutics Inc.

 
Japan

Mitsubishi Tanabe Pharma

 
United States

Mitsubishi Tanabe Pharma Holdings America, Inc.

 
 
United States

Mitsui & Co. Global Investment, Inc.

 
Japan

Mochida Pharmaceutical CO., LTD

 
United States

Modality.AI, Inc.

 
United States

Model Medicines

 
United States

Modulim, Inc.

 
Japan

MOLCURE

 
 
United States

Molex Ventures LLC

 
 
United Kingdom

Momentum Biotech

 
 
United States

Moore Venture Partners

 
United Kingdom

Morgan Prestwich

 
 
United States

MP HEALTHCARE VENTURE MANAGEMENT INC

 
 
United States

MRL Ventures Fund

 
United States

MSQ Ventures

 
South Korea

MTHERAPHARMA. Co., Ltd.

 
 
United States

Mubadala Capital

 
United States

Multimeric Biotherapeutics, Inc.

 
United States

Multiomic Advisory Services

 
United Kingdom

Multiomic Health

 
United States

MVT Pharma LLC

 
United States

MyData TRUST

 
United States

MYMD Pharmaceuticals Inc.

 
United States

NAKI Therapeutics

 
United States

Nammi Therapeutics, Inc.

 
France

Nanobiotix

 
United States

NanOlogy Cancer Therapeutics

 
Canada

Nanology Labs Inc.

 
United States

Nanopec, Inc.

 
United States

NanoTomer, inc

 
United States

NanoView Biosciences

 
United Kingdom

National institute for health Research (NIHR)

 
United States

National Institutes of Health, National Cancer Institute, Technology Transfer Center

 
United States

Navega Therapeutics

 
United Kingdom

NavigatorBio

 
Japan

NB Health Laboratory Co. Ltd.

 
 
United States

NCL Technology Ventures Ltd.

 
 
United States

NDH Fund

 
United States

Nectin Therapeutics

 
 
France

Negma Group

 
United States

NeoImmuneTech

 
Germany

NeoPrediX

 
United States

NeoProgen

 
United States

NephroSant

 
United Kingdom

NeRRe Therapeutics

 
United States

Nervonik, Inc.

 
United States

Neumentum Inc

 
South Korea

Neuramedy

 
United States

Neurodon Corporation

 
United States

Neurofenix Inc

 
United States

NeuroPn Therapeutics

 
United States

Neurotech Reports

 
Germany

Neuway Pharma GmbH

 
 
United States

New Enterprise Associates

 
 
United States

New Mexico Angels

 
United States

New Perspectives, Inc.

 
 
United States

New Rhein Healthcare Investors

 
 
United Kingdom

New Science Ventures

 
United States

NexImmune

 
Canada

NexPlasmaGen incorporated

 
 
Thailand

Nexter Ventures Co., Ltd

 
South Korea

Nextgen Bioscience

 
South Korea

NexThera Co., Ltd.

 
United States

NextPhase Therapeutics, Inc.

 
United States

NextVivo, Inc.

 
South Korea

NIBEC Co.,Ltd.

 
 
Switzerland

Nice & Green SA

 
China

Nicoya Therapeutics

 
 
United States

Nieuw Amsterdam Advisors

 
Japan

NIFCO

 
United States

NIH/NIA/DN/OSBR

 
United States

Nkarta, Inc.

 
United States

NKILT Therapeutics Inc.

 
United States

No Patient Left Behind

 
Japan

Nobelpharma

 
United Kingdom

NOCRI

 
 
Switzerland

Nodes Advisors AG

 
Norway

Nordic Nanovector ASA

 
 
United States

Northlea Partners LLLP

 
 
United States

Northpond Ventures

 
 
United Kingdom

Novalis

 
United States

Novian Health

 
Denmark

Novo Nordisk

 
Australia

Novotech

 
 
United States

NSIP LLC

 
Australia

Nucleus Network

 
 
United States

NYCC LLC

 
 
United Kingdom

o2h Ventures Ltd

 
 
Puerto Rico

Oasis Capital LLC

 
 
United States

Oberland Capital Management, LLC

 
United States

OBI Pharma, Inc.

 
United States

Obsidio, Inc.

 
United States

ObvioHealth

 
 
United States

OCA Ventures

 
 
United States

Oceaniq Capital Partners

 
Russian Federation

OCT Clinical

 
 
United States

OCV Partners

 
United States

OKYO Pharma Ltd

 
France

OLGRAM

 
South Korea

OliPass Corporation

 
South Korea

OliX Pharmaceuticals

 
Hungary

Omixon Biocomputing Kft

 
Malta

Omniscope

 
Finland

OncoBone Ventures Ltd

 
South Korea

ONCOCROSS

 
France

Oncodesign Biotechnology

 
France

Oncodesign SERVICES

 
 
United States

Oncology Impact Partners

 
Australia

Oncology One Pty Ltd

 
South Korea

Onconic

 
United States

OncoSynergy

 
 
United States

Onelife Fund SA Bluestar Investment Managers SA

 
United States

Only Orphans Cote LLC

 
United States

ONO Pharma, USA Inc,.

 
 
United States

Ono Venture Investment

 
United States

OnQuality Pharmaceuticals

 
United States

Oppenheimer & Co Inc

 
Canada

Optina Diagnostics

 
 
United States

Orange Grove Bio

 
 
United States

OrbiMed

 
United Kingdom

Orbit Discovery

 
 
United States

Oregon Venture Fund

 
 
United States

Oresund Capital

 
United States

Origami Therapeutics, Inc.

 
United States

Orinove, Inc

 
United States

ORintelligence

 
 
United States

ORIX Growth Capital

 
United States

Oryn Therapeutics

 
Spain

Oryzon Genomics, S.A

 
United States

OS Therapies Inc

 
South Korea

Oscotec Inc.

 
 
United States

OSF Healthcare Ventures

 
 
United States

Otsuka (MSRD)

 
 
Israel

OTV (Olive Tree Ventures) fund

 
United States

OVID THERAPEUTICS

 
United States

OX2 Therapeutics

 
United Kingdom

Oxford Biomedica

 
United Kingdom

Oxford Medical Products

 
United Kingdom

OxSonics Therapeutics

 
United States

OYE Therapeutics Inc

 
Canada

Pacylex Pharmaceuticals, Inc.

 
United States

PainQx

 
United States

Palisade Bio

 
 
China

Panacea Venture

 
 
Italy

Panakes Partners SGR Spa

 
 
United States

Pandect Bioventures

 
United Kingdom

Pangaea Data

 
 
United States

Pangaea Ventures Ltd.

 
 
United States

Pappas Capital

 
United States

Paracrine, Inc.

 
 
South Korea

Paratus Investment

 
United States

Parexel

 
 
United States

Particular Ventures LLC

 
 
United States

Pathway Bioventures

 
 
United States

Peak One Investments, LLC

 
 
Israel

Peregrine Ventures

 
France

Perha Pharmaceuticals SAS

 
United States

Peter Biotherapeutics

 
United States

PhageNova Bio, Inc.

 
United States

Phanes Therapeutics, Inc.

 
 
United States

Pharma Capital Partners

 
South Korea

PharmAbcine Inc.

 
 
United States

PharmaCatalyst

 
United States

PharmaDirections

 
United States

PharmaLex US Corp

 
United Kingdom

PharmaVentures Ltd

 
South Korea

PharmCADD Co., Ltd.

 
 
United States

Phoenix Venture Partners

 
United Kingdom

PhoreMost

 
France

Phost'in Therapeutics

 
 
United States

Photon Venture Capital

 
United States

PhotoniCare

 
United States

PIC Therapeutics, Inc.

 
 
United States

Pilatus Capital

 
United States

Pin Therapeutics

 
United States

PineTree Therapeutics

 
United States

Pink Cloud LLC

 
United Kingdom

Piramal Pharma Solutions

 
 
United States

Pivotal bioVenture Partners

 
 
United States

Pivotal Life Sciences

 
France

PKVITALITY

 
United States

Pliancy

 
United States

Plus Therapeutics

 
 
United States

PMM /Investor Intelligence

 
United Kingdom

Pneumagen Ltd

 
 
United States

PoC Capital, LLC

 
United States

PolyPeptide Group

 
United States

POP Biotechnologies

 
Japan

PorMedTec.,Co.,Ltd

 
United States

Prasco

 
United States

Prellis Biologics, Inc

 
United States

Premier Consulting

 
United States

Presagen

 
Australia

Prescient Therapeutics

 
 
United States

Prevail Partners LLC

 
United States

Preverna Inc.

 
United States

Prima Innovation LLC

 
Canada

Primary Peptides

 
 
United States

Prime Movers Lab

 
United States

Privo Technologies

 
 
United States

Profound Ventures and Cancer Fund

 
United Kingdom

Prokarium

 
United States

Prolocor Inc

 
United States

ProMIS Neurosciences

 
United States

Prothena Biosciences

 
United States

ProTrials Research, Inc.

 
 
United States

PsyMed Ventures

 
United States

Pullan Consulting

 
Netherlands

PureIMS

 
Canada

PurMinds NeuroPharma Inc.

 
Israel

PURPLE BIOTECH

 
United States

Qilu Pharmaceutical Group

 
 
United States

Qiming Venture Partners

 
United States

QT Medical Inc

 
 
China

Quan Capital

 
Japan

Quantum Operation Inc.

 
United States

Quotient Sciences

 
United States

RADBIO USA, Inc.

 
Australia

Radiopharm Theranostics

 
China

Raffles PharmaTech Co., Ltd

 
 
Ireland

Raglan Capital

 
United Kingdom

RAIR Health Limited

 
Canada

Rakovina Therapeutics Inc.

 
United States

Rakuten Medical, Inc.

 
United States

Rallybio LLC

 
United States

Rancho Santa Fe Bio, Inc

 
United States

Rational Vaccines

 
 
United States

Ravi Mistry

 
 
Canada

Raymond James

 
 
Russian Federation

RBV Capital

 
United States

REBUS BIOSYSTEMS, INC

 
United States

Recro Pharma San Diego

 
 
Switzerland

Redalpine Venture Partners

 
 
United States

REDDS Capital

 
 
United States

Reed-Ventures

 
Singapore

Regeneus

 
Switzerland

Rejuveron

 
 
Canada

Relentless Venture Fund

 
United States

Relevant Biosciences

 
United States

Relief Therapeutics Holding SA

 
United States

Remedy Plan Therapeutics

 
 
Japan

Remiges Ventures

 
United States

Ren Bioscience

 
United States

Reneo Pharmaceuticals, Inc

 
United Kingdom

Renovos Biologics

 
United States

RespireRx Pharma Inc

 
United States

Respirix

 
Japan

Restore Vision, Inc.

 
Canada

Reveal Surgical

 
United States

ReviveMed Inc.

 
United States

Revlar Labs

 
 
United States

Ridgeback

 
 
United States

River Cities Capital

 
 
United States

RiverVest Venture Partners

 
United States

RNatives Inc.

 
United States

Ronawk

 
China

Rongchang Pharmaceuticals

 
United States

RoosterBio

 
United States

Roswell Park Comprehensive Cancer Center

 
United States

R-Pharm

 
United States

RS Oncology LLC

 
 
United States

RTH

 
United States

RubrYc Therapeutics, Inc.

 
 
United States

Sacramento Angels

 
United States

Safi Biosolutions, Inc.

 
 
Canada

Sagard Healthcare Royalty Partners

 
United States

Sage Group, Inc.

 
 
United States

Saisei Ventures

 
United States

Salarius Pharmaceuticals

 
South Korea

Samsung Biologics

 
 
South Korea

Samsung Biologics LS Fund

 
 
South Korea

Samsung Venture Investment Corporation

 
United States

Samyang Biopharm USA Inc

 
United States

San Francisco Business Times

 
 
United Kingdom

Sanan Capital

 
 
United States

Sandhill Angels

 
 
United States

Santen, Inc.

 
United States

Sartorius North America

 
Canada

Satellos Bioscience Inc.

 
 
United States

Satter Investment Mangement

 
Denmark

Scandion Oncology A/S

 
United Kingdom

Scendea Ltd

 
 
Singapore

Schmidt Deng Ventures Pte. Ltd

 
 
United States

Schooner Capital LLC

 
United States

ScienceBoard

 
United Kingdom

Sciensus Rare

 
Australia

Scientia Clinical Research

 
United States

Scientific American

 
 
United States

Scientific Health Development Partners

 
 
United States

SciFounders GP, LLC

 
United States

SciMount Pharmatech

 
United Kingdom

Scius Communications

 
Japan

SCOHIA PHARNA, Inc.

 
 
United States

Scotasian Capital

 
 
United States

Scott Michael Partners LLC

 
United States

Scrip/The Pink Sheet

 
 
United States

SDL Ventures, LLC

 
France

Sea Be Life

 
 
Canada

Sectoral Asset Management

 
 
United States

SeedFolio

 
Japan

SEEDSUPPLY

 
South Korea

Selecxine

 
France

SENSOME

 
United States

Seran BioScience

 
United States

Serina Therapeutics, Inc.

 
 
Ireland

Seroba Life Sciences

 
United States

Servier BioInnovation

 
 
South Korea

SevenTree Equity Partners Co., Ltd.

 
 
France

Seventure

 
China

Shanghai Allist Pharmaceuticals Co., Ltd

 
China

Shanghai Henlius Biotech, Inc.

 
United States

Shasqi, Inc.

 
 
United States

Shaw Strategic Capital

 
 
Japan

Shinsei Capital Partners

 
Canada

SignalChem Lifesciences Corp

 
 
United States

Silicon Valley Bank

 
United States

Simcere Pharma

 
United States

Sirpant Immunotherapeutics Inc.

 
United States

Siva Therapeutics, Inc.

 
 
Canada

Sixty Degree Capital

 
South Korea

SK Biopharmaceuticals

 
 
South Korea

SM -Sino Technology Investment Co., Ltd.

 
 
South Korea

smilegate asset management

 
Japan

Socium Inc

 
Mexico

Sophia

 
Japan

SOUSEIKAI Global

 
Australia

Southern Star Research

 
United States

Spartan Capital

 
United States

Spear Bio Inc.

 
Canada

Spiderwort Inc

 
 
United States

Sprim Global Investments

 
 
United States

SpringRock Ventures

 
Sweden

Sprint Bioscience

 
South Korea

Standup Science

 
Israel

Star Tree Ventures Ltd.

 
United States

Starton Therapeutics

 
United States

Startup Health

 
United States

STAT

 
United States

Statera Biopharma

 
United States

Statistics and Data Corporation (SDC)

 
United States

STATKING Clinical Services

 
France

Stellate Therapeutics

 
United States

StemBioSys, Inc.

 
 
United States

SternAegis Ventures LLC

 
 
United States

Stonehaven Incubate AG

 
United States

Stuart Therapeutics, Inc.

 
Japan

Sumitomo Dainippon Pharma

 
United States

Sumitovant Biopharma, Inc.

 
Japan

Summit Pharmaceuticals International

 
United States

Sun Genomics, Inc.

 
 
Denmark

Sunstone Life Science Ventures

 
 
United States

SV Health Investors

 
 
South Korea

SV Investment

 
 
United States

SVB Capital

 
United States

Swiss Business Hub USA

 
 
United States

SWK Holdings Corporation

 
United States

Syapse

 
Netherlands

Symeres B.V.

 
Netherlands

Synaffix B.V.

 
Taiwan

Syncell Inc.

 
Taiwan

SynCore Biotechnology

 
United States

Syneos Health

 
 
South Korea

Synergy IB Investment

 
 
United States

Synergy Ventures

 
 
United States

Syno Capital, LLC

 
 
United States

syzygy therapeutics

 
United States

T2MED, Inc.

 
 
United States

Taiho Ventures, LLC.

 
Japan

Taisho Pharmaceutical Co., Ltd.

 
Japan

Takanawa Pharma

 
 
United States

Talfinium Investments Inc.

 
Canada

TALLC Corporation Inc.

 
United States

Talus Bioscience, Inc

 
 
Italy

Tandem Ventures

 
Portugal

TargTex S.A.

 
United Kingdom

TAUC3 BIOLOGICS LIMITED

 
United Kingdom

TauRx Pharmaceuticals Ltd

 
United Kingdom

T-Cypher Bio Ltd

 
 
United States

Tech Coast Angels - San Diego

 
United States

<